Skip to main content

Advertisement

Log in

Effect of equiguard in treating patients with Shen-yang deficiency syndrome

  • Clinical Experience
  • Published:
Chinese Journal of Integrative Medicine Aims and scope Submit manuscript

Abstract

Objective

To observe the therapeutic effect of Equiguard in old patients with Shen (肾)-yang deficiency syndrome (SYDS).

Methods

Twenty old patients with diagnosis matching the criteria of SYDS selected from out-patients were administered with Equiguard capsule 3 times per day, 0.70 g each time for 3 successive months. The changes in general condition, peripheral blood picture, function of the liver and kidney, and sex hormones before and after treatment were observed. The changes in the American Urinary Surgery Association (AUA) score of prostatism, urosis and residue urine in the urinary bladder were also estimated.

Results

After the 3-month treatment, no significant change was found in the patients’ general condition, peripheral blood picture, liver and kidney function and sex hormones, while the symptoms of prostatism and urosis were markedly improved (P<0.01), and the volume of residue urine in the urinary bladder was obviously reduced.

Conclusion

Equiguard shows a significant therapeutic effect in treating old patients with SYDS, which could effectively improve the symptoms of prostatism and urosis in patients and is highly safe.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. He ZG. Traditional Chinese Medicine. 4th ed. Beijing: People’s Medical Publishing House, 1996:68.

    Google Scholar 

  2. Mebust W, Roizo R, Schroeder F, et al. Correlations between pathology, clinical symptoms and the course of the disease. In: Cockett ATK, Aso Y, Chatelain C, eds. Proceedings of the international consultation on benign prostatic hyperplasia. Geneva: WHO, 1991:51.

    Google Scholar 

  3. Shen ZY. Study of kidney (Continuation). Shanghai: Shanghai Scientific and Technical Publishers, 1990:313.

    Google Scholar 

  4. Chen DW, Meng YC, Fang XJ, et al. The progress and prospect of modern medical of Kidney Yang Vacuity pattern. Mod J Integr Tradit Chin West Med (Chin) 2005;14(23):3175–3177.

    Google Scholar 

  5. Liu FC. Role of Desertliving Cistanche in the DNA synthesis of kidney-yang deficiency animal caused by epimedium herb and hydroxyacrbamide. Chin J Integr Tradit West Med 1984;4(8):488.

    Google Scholar 

  6. Chen RQ. Effect of Epimedium grandiflorum and FUZI on sodium activity in erythrocyte membrane in rat. J Shanghai Univ 1986;13(5):387.

    Google Scholar 

  7. Liu SR. Progress of pharmacological study. Inform Tradit Chin Med (Chin) 1992;9(3):15.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Pei-hua Xiong  (熊佩华).

Additional information

Supported by The Hong Kong Association for Health Care

Rights and permissions

Reprints and permissions

About this article

Cite this article

Xiong, Ph., Zhang, L., Tian, Sf. et al. Effect of equiguard in treating patients with Shen-yang deficiency syndrome. Chin. J. Integr. Med. 14, 225–227 (2008). https://doi.org/10.1007/s11655-007-9007-1

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11655-007-9007-1

Key Words

Navigation